DGIST Library Repository

Browsing by Titles

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 3 of 3

Article
hMAGEA2 Accelerates the Progression of Prostate Cancer via the EFNA3-Erk1/2 Signaling Pathway
  • Han, Sehyeon ; 
  • Jang, Soyoung ; 
  • Lee, Seoung-Woo ; 
  • Kim, Hee-Yeon ; 
  • Kim, Wansoo ; 
  • Kim, Hyeon-Gyeom ; 
  • Park, Jin-Kyu ; 
  • Han, Jee Eun ; 
  • Ryoo, Zae Young ; 
  • Seah, Ethan ; 
    • et al
  • 2024-07
  • Han, Sehyeon. (2024-07). hMAGEA2 Accelerates the Progression of Prostate Cancer via the EFNA3-Erk1/2 Signaling Pathway. Anticancer Research, 44(7), 2847–2859. doi: 10.21873/anticanres.17097
  • International Institute of Anticancer Research
  • View : 152
  • Download : 0
Article
Inhibition of MAGEA2 regulates pluripotency, proliferation, apoptosis, and differentiation in mouse embryonic stem cells
  • Park, Song ; 
  • Han, Jee Eun ; 
  • Kim, Hyeon-Gyeom ; 
  • Kim, Hee‐Yeon ; 
  • Kim, Min‐Gi ; 
  • Park, Jin-Kyu ; 
  • Cho, Gil-Jae ; 
  • Huang, Hai ; 
  • Kim, Myoung Ok ; 
  • Ryoo, Zae Young ; 
    • et al
  • 2020-11
  • Park, Song. (2020-11). Inhibition of MAGEA2 regulates pluripotency, proliferation, apoptosis, and differentiation in mouse embryonic stem cells. Journal of Cellular Biochemistry, 121(11), 4667–4679. doi: 10.1002/jcb.29692
  • John Wiley & Sons Inc.
  • View : 762
  • Download : 0

ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state

Article
ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state
  • Kwon, Wookbong ; 
  • Choi, Seong-Kyoon ; 
  • Kim, Daehwan ; 
  • Kim, Hyeon-Gyeom ; 
  • Park, Jin-Kyu ; 
  • Han, Jee Eun ; 
  • Cho, Gil-Jae ; 
  • Yun, Sungho ; 
  • Yu, Wookyung ; 
  • Han, Se-Hyeon ; 
    • et al
  • 2021-09
  • Kwon, Wookbong. (2021-09). ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state. Journal of Experimental & Clinical Cancer Research, 40(1). doi: 10.1186/s13046-021-02094-3
  • Springer Science and Business Media LLC
  • View : 535
  • Download : 158
1